APA

Jiang M., Zhang L., Xie L., Zhang H., Jiang Y., Liu W., Zhang W., Tian R., Deng Y., Zhao S. & Zou L. (20180517). A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma. : Oncotarget.

Chicago

Jiang Ming, Zhang Li, Xie Li, Zhang Hong, Jiang Yu, Liu Wei-Ping, Zhang Wen-Yan, Tian Rong, Deng Yao-Tiao, Zhao Sha and Zou Li-Qun. 20180517. A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma. : Oncotarget.

Harvard

Jiang M., Zhang L., Xie L., Zhang H., Jiang Y., Liu W., Zhang W., Tian R., Deng Y., Zhao S. and Zou L. (20180517). A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma. : Oncotarget.

MLA

Jiang Ming, Zhang Li, Xie Li, Zhang Hong, Jiang Yu, Liu Wei-Ping, Zhang Wen-Yan, Tian Rong, Deng Yao-Tiao, Zhao Sha and Zou Li-Qun. A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma. : Oncotarget. 20180517.